Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Net Margin (2021)

Historic Net Margin for Cullinan Therapeutics (CGEM) over the last 1 years, with Q1 2021 value amounting to 7.49%.

  • Cullinan Therapeutics' Net Margin changed N/A to 7.49% in Q1 2021 from the same period last year, while for Dec 2021 it was 356.25%, marking a year-over-year change of. This contributed to the annual value of 356.25% for FY2021, which is N/A changed from last year.
  • As of Q1 2021, Cullinan Therapeutics' Net Margin stood at 7.49%.
  • In the past 5 years, Cullinan Therapeutics' Net Margin ranged from a high of 7.49% in Q1 2021 and a low of 7.49% during Q1 2021